世界の制吐薬市場予測（～2028年）：ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬

• 英文タイトル：Global Antiemetic Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8734 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

制吐薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の制吐薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 制吐薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬 用途別セグメントは次のように区分されます。 ・化学療法、胃腸炎、外科 世界の制吐薬市場の主要な市場プレーヤーは以下のとおりです。 ・GlaxoSmithKline、Johnson & Johnson、Pfizer、Sanofi、Abbott、Bristol-Myers Squibb、Cipla、Eisai、Eli Lilly、Glenmark、Helsinn Healthcare、Heron Therapeutics、IPCA Laboratories、Lupin、Merck、Novartis、RedHill、Sun Pharmaceutical Industries、Takeda Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、制吐薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な制吐薬メーカーの企業概要、2019年～2022年までの制吐薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な制吐薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別制吐薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの制吐薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での制吐薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および制吐薬の産業チェーンを掲載しています。 ・第13、14、15章では、制吐薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GlaxoSmithKline、Johnson & Johnson、Pfizer、Sanofi、Abbott、Bristol-Myers Squibb、Cipla、Eisai、Eli Lilly、Glenmark、Helsinn Healthcare、Heron Therapeutics、IPCA Laboratories、Lupin、Merck、Novartis、RedHill、Sun Pharmaceutical Industries、Takeda Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：ドーパミン拮抗薬、5-HT-3受容体拮抗薬、NK1受容体拮抗薬、カンナビノイド受容体拮抗薬 ・用途別分析2017年-2028年：化学療法、胃腸炎、外科 ・制吐薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・制吐薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・制吐薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・制吐薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン ・制吐薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Antiemetic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antiemetic Drugs market size is estimated to be worth US$ 4893.3 million in 2021 and is forecast to a readjusted size of USD 6556.4 million by 2028 with a CAGR of 4.3% during review period. Chemotherapy accounting for % of the Antiemetic Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Dopamine Antagonist segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antiemetic Drugs include GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, and Abbott, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antiemetic Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
Market segment by Application can be divided into
Chemotherapy
Gastroenteritis
Surgery
The key market players for global Antiemetic Drugs market are listed below:
GlaxoSmithKline
Johnson & Johnson
Pfizer
Sanofi
Abbott
Bristol-Myers Squibb
Cipla
Eisai
Eli Lilly
Glenmark
Helsinn Healthcare
Heron Therapeutics
IPCA Laboratories
Lupin
Merck
Novartis
RedHill
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antiemetic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antiemetic Drugs, with price, sales, revenue and global market share of Antiemetic Drugs from 2019 to 2022.
Chapter 3, the Antiemetic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiemetic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antiemetic Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiemetic Drugs.
Chapter 13, 14, and 15, to describe Antiemetic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Antiemetic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antiemetic Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Dopamine Antagonist
1.2.3 5-HT-3 Receptor Antagonist
1.2.4 NK1 Receptor Antagonist
1.2.5 Cannabinoid Receptor Antagonist
1.3 Market Analysis by Application
1.3.1 Overview: Global Antiemetic Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chemotherapy
1.3.3 Gastroenteritis
1.3.4 Surgery
1.4 Global Antiemetic Drugs Market Size & Forecast
1.4.1 Global Antiemetic Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antiemetic Drugs Sales in Volume (2017-2028)
1.4.3 Global Antiemetic Drugs Price (2017-2028)
1.5 Global Antiemetic Drugs Production Capacity Analysis
1.5.1 Global Antiemetic Drugs Total Production Capacity (2017-2028)
1.5.2 Global Antiemetic Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antiemetic Drugs Market Drivers
1.6.2 Antiemetic Drugs Market Restraints
1.6.3 Antiemetic Drugs Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Antiemetic Drugs Product and Services
2.1.4 GlaxoSmithKline Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Antiemetic Drugs Product and Services
2.2.4 Johnson & Johnson Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Antiemetic Drugs Product and Services
2.3.4 Pfizer Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Antiemetic Drugs Product and Services
2.4.4 Sanofi Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Antiemetic Drugs Product and Services
2.5.4 Abbott Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Antiemetic Drugs Product and Services
2.6.4 Bristol-Myers Squibb Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Antiemetic Drugs Product and Services
2.7.4 Cipla Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eisai
2.8.1 Eisai Details
2.8.2 Eisai Major Business
2.8.3 Eisai Antiemetic Drugs Product and Services
2.8.4 Eisai Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Antiemetic Drugs Product and Services
2.9.4 Eli Lilly Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Glenmark
2.10.1 Glenmark Details
2.10.2 Glenmark Major Business
2.10.3 Glenmark Antiemetic Drugs Product and Services
2.10.4 Glenmark Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Helsinn Healthcare
2.11.1 Helsinn Healthcare Details
2.11.2 Helsinn Healthcare Major Business
2.11.3 Helsinn Healthcare Antiemetic Drugs Product and Services
2.11.4 Helsinn Healthcare Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Heron Therapeutics
2.12.1 Heron Therapeutics Details
2.12.2 Heron Therapeutics Major Business
2.12.3 Heron Therapeutics Antiemetic Drugs Product and Services
2.12.4 Heron Therapeutics Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 IPCA Laboratories
2.13.1 IPCA Laboratories Details
2.13.2 IPCA Laboratories Major Business
2.13.3 IPCA Laboratories Antiemetic Drugs Product and Services
2.13.4 IPCA Laboratories Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Lupin
2.14.1 Lupin Details
2.14.2 Lupin Major Business
2.14.3 Lupin Antiemetic Drugs Product and Services
2.14.4 Lupin Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Merck
2.15.1 Merck Details
2.15.2 Merck Major Business
2.15.3 Merck Antiemetic Drugs Product and Services
2.15.4 Merck Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Novartis
2.16.1 Novartis Details
2.16.2 Novartis Major Business
2.16.3 Novartis Antiemetic Drugs Product and Services
2.16.4 Novartis Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 RedHill
2.17.1 RedHill Details
2.17.2 RedHill Major Business
2.17.3 RedHill Antiemetic Drugs Product and Services
2.17.4 RedHill Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Sun Pharmaceutical Industries
2.18.1 Sun Pharmaceutical Industries Details
2.18.2 Sun Pharmaceutical Industries Major Business
2.18.3 Sun Pharmaceutical Industries Antiemetic Drugs Product and Services
2.18.4 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Takeda Pharmaceutical
2.19.1 Takeda Pharmaceutical Details
2.19.2 Takeda Pharmaceutical Major Business
2.19.3 Takeda Pharmaceutical Antiemetic Drugs Product and Services
2.19.4 Takeda Pharmaceutical Antiemetic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antiemetic Drugs Breakdown Data by Manufacturer
3.1 Global Antiemetic Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antiemetic Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antiemetic Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Antiemetic Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Antiemetic Drugs Manufacturer Market Share in 2021
3.5 Global Antiemetic Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antiemetic Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antiemetic Drugs Market Size by Region
4.1.1 Global Antiemetic Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Antiemetic Drugs Revenue by Region (2017-2028)
4.2 North America Antiemetic Drugs Revenue (2017-2028)
4.3 Europe Antiemetic Drugs Revenue (2017-2028)
4.4 Asia-Pacific Antiemetic Drugs Revenue (2017-2028)
4.5 South America Antiemetic Drugs Revenue (2017-2028)
4.6 Middle East and Africa Antiemetic Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antiemetic Drugs Sales in Volume by Type (2017-2028)
5.2 Global Antiemetic Drugs Revenue by Type (2017-2028)
5.3 Global Antiemetic Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antiemetic Drugs Sales in Volume by Application (2017-2028)
6.2 Global Antiemetic Drugs Revenue by Application (2017-2028)
6.3 Global Antiemetic Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antiemetic Drugs Sales by Type (2017-2028)
7.2 North America Antiemetic Drugs Sales by Application (2017-2028)
7.3 North America Antiemetic Drugs Market Size by Country
7.3.1 North America Antiemetic Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Antiemetic Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antiemetic Drugs Sales by Type (2017-2028)
8.2 Europe Antiemetic Drugs Sales by Application (2017-2028)
8.3 Europe Antiemetic Drugs Market Size by Country
8.3.1 Europe Antiemetic Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Antiemetic Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antiemetic Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Antiemetic Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Antiemetic Drugs Market Size by Region
9.3.1 Asia-Pacific Antiemetic Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antiemetic Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antiemetic Drugs Sales by Type (2017-2028)
10.2 South America Antiemetic Drugs Sales by Application (2017-2028)
10.3 South America Antiemetic Drugs Market Size by Country
10.3.1 South America Antiemetic Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Antiemetic Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antiemetic Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Antiemetic Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Antiemetic Drugs Market Size by Country
11.3.1 Middle East & Africa Antiemetic Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antiemetic Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antiemetic Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antiemetic Drugs
12.3 Antiemetic Drugs Production Process
12.4 Antiemetic Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antiemetic Drugs Typical Distributors
13.3 Antiemetic Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---